Patent intelligence · US
US 8636988
Composition for treatment of sunburned skin
Composition for treatment of sunburned skin
Patent details — US 8636988
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 28, 2014
- Expiration
- Jan 23, 2034
- Applicant
- Doctor Essentials
- Claims
- 5
- CPC classes
- A61K, A61K31/167, A61K31/573, A61K36/886
Quick answer
US 8636988 (Composition for treatment of sunburned skin) is held by Doctor Essentials. Status: granted. Granted Jan 28, 2014. Expires Jan 23, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Doctor Essentials
- Grant date
- Expiration
- Claims
- 5
- CPC classes
- A61K, A61K31/167, A61K31/573, A61K36/886, A61K45/00, A61K45/06
More from Doctor Essentials
Related pharmaceutical patents in our USPTO index.
-
US 12419895
Methods for treating subjects with Prader-Willi syndrome
granted -
US 12350258
Compositions and methods for treatment of skin-related diseases and promoting dermatological health
granted -
US 12343348
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12343381
Dosage regimen for pegylated interferon
granted -
US 12178823
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12109216
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12005081
Chimeric receptors and methods of use thereof
granted -
US 11884656
Pyrrole derivatives as PLK1 inhibitors
granted
Frequently asked questions
What is US patent 8636988?
US 8636988 (Composition for treatment of sunburned skin) is held by Doctor Essentials. Status: granted. Granted Jan 28, 2014. Expires Jan 23, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8636988?
Doctor Essentials is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 95 pharmaceutical patents for this assignee.
When does US 8636988 expire?
Our index shows an expiration date of Jan 23, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.